APO RESEARCH · REPORT
Nuclear Medicine & Radiopharmaceuticals
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Product & engineering
Understand the product.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
Selected research
Industry Research
Nuclear Medicine & Radiopharmaceuticals Industry Research Report 2026
Market perspective
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
Report Scope
Read the full market overview
This report quantifies the global Nuclear Medicine & Radiopharmaceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nuclear Medicine & Radiopharmaceuticals Market by Company
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Nuclear Medicine & Radiopharmaceuticals Segment by Type
Diagnostic
Therapeutic
Nuclear Medicine & Radiopharmaceuticals Segment by Application
Oncology
Thyroid
Cardiology
Others
Nuclear Medicine & Radiopharmaceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine & Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine & Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine & Radiopharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nuclear Medicine & Radiopharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nuclear Medicine & Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostic
- Therapeutic
Applications
- Oncology
- Thyroid
- Cardiology
- Others
Companies covered
- China Isotope & Radiation
- Dongcheng
- Jaco
- Ciaeriar
- Advanced Molecular-imaging Solution
- Shanghai Atom Kexing
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size (2021-2032)
- 2.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales (2021-2032)
- 2.2.3 Global Nuclear Medicine & Radiopharmaceuticals Market Average Price (2021-2032)
- 2.3 Nuclear Medicine & Radiopharmaceuticals by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Diagnostic
- 2.3.3 Therapeutic
- 2.4 Nuclear Medicine & Radiopharmaceuticals by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncology
- 2.4.3 Thyroid
- 2.4.4 Cardiology
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue of Manufacturers (2021-2026)
- 3.4 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2021-2026)
- 3.5 Global Nuclear Medicine & Radiopharmaceuticals Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Product Type & Application
- 3.8 Global Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Established Date
- 3.9 Global Nuclear Medicine & Radiopharmaceuticals Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 China Isotope & Radiation
- 4.1.1 China Isotope & Radiation Company Information
- 4.1.2 China Isotope & Radiation Business Overview
- 4.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio
- 4.1.5 China Isotope & Radiation Recent Developments
- 4.2 Dongcheng
- 4.2.1 Dongcheng Company Information
- 4.2.2 Dongcheng Business Overview
- 4.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio
- 4.2.5 Dongcheng Recent Developments
- 4.3 Jaco
- 4.3.1 Jaco Company Information
- 4.3.2 Jaco Business Overview
- 4.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio
- 4.3.5 Jaco Recent Developments
- 4.4 Ciaeriar
- 4.4.1 Ciaeriar Company Information
- 4.4.2 Ciaeriar Business Overview
- 4.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio
- 4.4.5 Ciaeriar Recent Developments
- 4.5 Advanced Molecular-imaging Solution
- 4.5.1 Advanced Molecular-imaging Solution Company Information
- 4.5.2 Advanced Molecular-imaging Solution Business Overview
- 4.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio
- 4.5.5 Advanced Molecular-imaging Solution Recent Developments
- 4.6 Shanghai Atom Kexing
- 4.6.1 Shanghai Atom Kexing Company Information
- 4.6.2 Shanghai Atom Kexing Business Overview
- 4.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio
- 4.6.5 Shanghai Atom Kexing Recent Developments
5 Global Nuclear Medicine & Radiopharmaceuticals Market Scenario by Region
- 5.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2021-2032
- 5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2021-2026
- 5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2027-2032
- 5.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2021-2032
- 5.3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2021-2026
- 5.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2027-2032
- 5.4 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
- 5.4.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2032)
- 5.4.3 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
- 5.5.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2032)
- 5.5.3 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
- 5.7.1 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2032)
- 5.7.3 South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032)
- 6.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2021-2032)
- 6.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2032)
- 6.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
- 6.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032)
- 7.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2021-2032)
- 7.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2032)
- 7.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
- 7.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nuclear Medicine & Radiopharmaceuticals Value Chain Analysis
- 8.1.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process
- 8.2 Nuclear Medicine & Radiopharmaceuticals Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nuclear Medicine & Radiopharmaceuticals Distributors
- 8.2.3 Nuclear Medicine & Radiopharmaceuticals Customers
9 Global Nuclear Medicine & Radiopharmaceuticals Analyzing Market Dynamics
- 9.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
- 9.2 Nuclear Medicine & Radiopharmaceuticals Industry Drivers
- 9.3 Nuclear Medicine & Radiopharmaceuticals Industry Opportunities and Challenges
- 9.4 Nuclear Medicine & Radiopharmaceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst